POMALIDOMIDE
pomalidomide 4 mg capsule, 21
POMALIDOMIDE (10387Q)
10387Q
Manner of administration:Oral
Restriction
Indication: Multiple myeloma
Treatment phase: Initial treatment - dual therapy in combination with dexamethasone
Restriction
Indication: Multiple myeloma
Treatment phase: Continuing treatment - dual therapy in combination with dexamethasone
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 21 | # of repeats: 0 | DPMQ: $1,412.15 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Pomalidomide Sandoz | |||||
| Pomolide | |||||